Bach; Fritz H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bach; Fritz H..The latest application filed is for "methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation".

Company Profile

0.8.11

Bach; Fritz H. - Manchester By The Sea MA
Bach; Fritz H. - Manchester-by-the-sea MA
Bach; Fritz H. - Manchester MA
Bach, Fritz H. - Boston MA
Bach, Fritz H. - Mancester-by-the-sea MA
Bach; Fritz H. - Minneapolis MN
Bach; Fritz H. - Madison WI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treating Inflammation By Administration Of Heme Oxygenase-1 And Products Of Heme Degradation App 20120195976 - Bach; Fritz H. ; et al.	2012-08-02
Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation Grant 8,097,585 - Bach , et al. January 17, 2	2012-01-17
Methods of treating vascular disease Grant 7,691,416 - Otterbein , et al. April 6, 2	2010-04-06
Pharmaceutical Use Of Nitric Oxide, Heme Oxygenase-1 And Products Of Heme Degradation App 20080171021 - Bach; Fritz H. ; et al.	2008-07-17
Methods Of Treating Vascular Disease App 20080167609 - Otterbein; Leo E. ; et al.	2008-07-10
Methods of treating vascular disease Grant 7,364,757 - Otterbein , et al. April 29, 2	2008-04-29
Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis App 20070202083 - Bach; Fritz H. ; et al.	2007-08-30
Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis Grant 7,238,469 - Bach , et al. July 3, 2	2007-07-03
ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means there for App 20060182733 - Bach; Fritz H. ; et al.	2006-08-17
Spinner preparation machine and cavity resonator App 20060003922 - Bach; Fritz H. ; et al.	2006-01-05
ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means therefor App 20040148645 - Bach, Fritz H. ; et al.	2004-07-29
Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation App 20040131703 - Bach, Fritz H. ; et al.	2004-07-08
Methods of treating vascular disease App 20030219496 - Otterbein, Leo E. ; et al.	2003-11-27
ATP-diphosphohydrolases, process of purification thereof and process of producing thereof by recombinant technology App 20030040094 - Beaudoin, Adrien R. ; et al.	2003-02-27
Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis App 20030039638 - Bach, Fritz H. ; et al.	2003-02-27
DNA and amino acid sequence specific for natural killer cells Grant 6,262,244 - Houchins , et al. July 17, 2	2001-07-17
Method of culturing lymphocytes and method of treatment using such lymphocytes Grant 5,443,983 - Ochoa , et al. August 22, 1	1995-08-22
Method for typing human leukocyte antigens Grant 4,265,873 - Sheehy , et al. May 5, 1	1981-05-05
Method for preparing a reagent for PLT and method of use Grant 4,124,701 - Bach , et al. November 7, 1	1978-11-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.